• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure

Novel Cell Lines Carrying Mutations in DNA Repair and Cancer Associated Genes

At a Glance

Researchers at Colorado State University have developed novel cell lines which have been modified to not allow DNA repair. These cells can be utilized in experiments to study drugs targeting specific gene mutant cells such as BRCA1 mutated cells. These cells lines, based on the well characterized Chinese hamster CHO cells and V79 cells, grow rapidly and can be effectively used to screen drugs in development.

Background

There is a large gap in the panel of Chinese Hamster mutant cell lines, which are model mammalian cell lines. These cell lines have been engineered to have mutations in ATM, ATR, or BRCA1.

Overview

These cell lines have been engineered to have mutations in ATM, ATR, BRCA1, which allow of precise analysis in radiobiology and cancer biology. Using CRISPR/Cas9, 5 cell lines were established, 2 which are knockouts of ATM and two mutants of ATR, and 1 mutant of BRCA1.

Figure 1. CHO Cells showing ATR mutation

Benefits

• Study DNA damage response for genes such as ATM, ATR, or BRCA1
• Good models for impaired ATR function and Seckel syndrome
• Easily research specific gene mutations
• Stable chromosome number

Applications

  • Drug screening
  • Cell-based assays

Publications

Kato, et al, 2024 “ATM and ATR gene editing mediated by CRISPR/Cas9 in Chinese Hamster cells” Mutat Res doi: 10.1016/j.mrfmmm.2024.111871

Kato et al 2024 “Palmitoyl ascorbic acid glucoside enhanced cell survival with post irradiation treatment” Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2023.149386

Last Updated: January 2025
Opportunity

Available for Non-Exclusive Licensing

IP Status

Materials Only

Inventors

Takamitsu Kato
Junko Maeda

Reference Number
2025-030
Licensing Manager

Steve Foster
Steve.Foster@colostate.edu
970-491-7100

Contact Us About this Technology
Download PDF
Download
Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect